| Cancer | ![]() |
Cell death | ![]() |
Cell cycle | ![]() |
Cytoskeleton | ![]() |
Exo/endocytosis | ![]() |
Differentiation | ![]() |
Division | ![]() |
Organelles | ![]() |
Signalling | ![]() |
Stem cells | ![]() |
Trafficking |
|
Editor-in-Chief DN Wheatley (Aberdeen, U.K.) Co-Editors Susan R. McGlashan (Auckland, New Zealand) Sidney S. Yu (Shatin, Hong Kong) Regional Editors H Carvalho (Campinas, Brazil) H Chang Chan (Shatin, Hong Kong) C Green (Auckland, New Zealand) S Kidson (Cape Town, South Africa) E Nadezhdina (Moscow, Russia) G Sluder (Worcester, U.S.A.) Managing Editor AJ Panther
(Aberdeen, U.K.) |
Cell Biology International (2010) 34, 109116 (Printed in Great Britain)
Green tea polyphenol (−)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells
Masayoshi Kamon, Ran Zhao and Kazuichi Sakamoto1
Recently, various physiological effects of the tea polyphenol catechin for alleviating diseases such as cancer, arteriosclerosis, hyperlipidaemia and osteoporosis have been reported. However, the physiological effect of catechin on bone metabolism remains unclear. We examined the physiological effect of EGCG [(−)-epigallocatechin-3-gallate], which is the main component of green tea catechin, on osteoblast development using the precursor cell line of osteoblasts, MC3T3-E1, and co-culture of the osteoblasts from mouse newborn calvaria and mouse bone marrow cells. Although EGCG did not affect the viability and proliferation of MC3T3-E1 cells, EGCG inhibited the osteoblast differentiation. Furthermore, EGCG did not affect the mineralization of differentiated MC3T3-E1 cells, and reduced osteoclast formation in co-culture. These results suggest that EGCG can effectively suppress bone resorption, and can be used as an effective medicine in the treatment of the symptoms of osteoporosis. Key words: catechin, osteoblast, polyphenol Abbreviations: 67LR, 67 kDa laminin receptor, ALP, alkaline phosphatase, α-MEM, minimum essential medium alpha medium, BMP, bone morphogenetic protein, CSF-1, colony stimulating factor-1, EC, (−)-epicatechin, ECG, (−)-epicatechin-3-gallate, EGC, (−)-epigallocatechin, EGCG, (−)-epigallocatechin-3-gallate, FBS, fetal bovine serum, G3PDH, glyceraldehyde 3-phosphate dehydrogenase, GST, glutathione transferase, MTT, 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide, NEAA, non-essential amino acid solution, OCN, osteocalcin, RANKL, receptor activator of nuclear factor κB ligand, TRAP, tartrate-resistant acid phosphatase 1To whom correspondence should be addressed (email sakamoto@biol.tsukuba.ac.jp). Received 17 March 2009/23 July 2009; accepted 15 September 2009 Published as Cell Biology International Immediate Publication 15 September 2009, doi:10.1042/CBI20090011 Journal compilation © 2010 Portland Press Ltd |
ISSN Print: 1065-6995
ISSN Electronic: 1095-8355 Published by Portland Press Limited on behalf of the International Federation for Cell Biology (IFCB) |